Consistent with our flow cytometric analysis (Figure 3C), single cell analysis of the 5 AML samples demonstrated that AHR-high samples have a lower percentage of mature CD56dim, CD94+/- CD16+ “stage 5” NK cells in the peripheral blood compared to AHR-low samples (Figure 4B). This evidence concerns the gene FCGR3A and acute myeloid leukemia.